AmyloiDia Sweden AB
Developing single-molecule sensitive blood tests for pre-symptomatic Alzheimer's diagnosis.
Oversigt
- 0
- Medarbejdere
- 100–149t SEK
- Omsætning
- 2019
- Grundlagt
Nøglebeslutningstagere
Dr Vladana Vukojević
CEO and Co-founder
Ann Tiiman
Co-founder and Researcher
Sebastian Wärmländer
Steering Board Member and Co-founder
Astrid Gräslund
Steering Board Chair and Co-founder
+15 flere kontakter i Funnelfeedr
Beskrivelse
AmyloiDia is an R&D-driven BioMedTech company dedicated to eradicating Alzheimer’s disease through early diagnosis. Their core mission involves translating advanced quantitative analytical methods into clinical healthcare applications. They have invented a novel, minimally invasive blood-based techn...